In vitro study of alkyl gallates as a growth inhibitor of cervical HeLa cancer cells
- 1 January 2024
- conference paper
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 3080 (1)
Abstract
Cervical cancer is the third most common cancer in women and the fifth most common in the world. In Indonesia, the prevalence of cervical cancer is 12.8 out ofKeywords
This publication has 11 references indexed in Scilit:
- Cervical Cancer Survivorship: Long-term Quality of Life and Social SupportClinical Therapeutics, 2015
- Posttraumatic Stress Disorder After High-Dose-Rate Brachytherapy for Cervical Cancer With 2 Fractions in 1 Application Under Spinal/Epidural Anesthesia: Incidence and Risk FactorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Gallic acid: Molecular rival of cancerEnvironmental Toxicology and Pharmacology, 2013
- Alkyl esters of gallic acid as anticancer agents: A reviewEuropean Journal of Medicinal Chemistry, 2013
- Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cellsEuropean Journal of Pharmacology, 2010
- Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increaseToxicology in Vitro, 2010
- Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosisFood and Chemical Toxicology, 2010
- In vitro screening for anthelmintic and antitumour activity of ethnomedicinal plants from ThailandJournal of Ethnopharmacology, 2009
- Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cellsBioorganic & Medicinal Chemistry, 2008
- Comparative cytotoxicity of alkyl gallates on mouse tumor cell lines and isolated rat hepatocytesComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2007